Document Detail


Incidence of spontaneous echocontrast, 'sludge' and thrombi before cardioversion in patients with atrial fibrillation: new insights into the role of transesophageal echocardiography.
MedLine Citation:
PMID:  19474574     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Transesophageal echocardiography (TEE)-guided cardioversion has been demonstrated to be well tolerated in patients with atrial fibrillation. Guidelines do not suggest whether patients with severe spontaneous echocontrast (SEC) and sludge can be safely submitted to cardioversion. In our observational study, we analyzed the prevalence of SEC in patients with atrial fibrillation taking different anticoagulant therapies, the incidence of embolic complications after cardioversion in patients with severe SEC or sludge and the usefulness of TEE in reducing embolic complications in these patients. METHODS: The study population consisted of 1104 patients with atrial fibrillation, candidates for cardioversion and submitted to TEE. They were divided into four groups: effective conventional oral anticoagulation, short-term anticoagulation, subtherapeutic anticoagulation and effective oral anticoagulation for less than 3 weeks for different clinical reasons. Cardioversion was postponed in patients with atrial thrombosis; in the presence of severe SEC, the decision to cardiovert was left to the treating physician. RESULTS: Atrial thrombosis was detected in 65 (5.9%) patients, and SEC was detected in the majority of patients independent of the anticoagulant scheme; in 131 patients, it was severe and, in this group, sludge was identified in 57 patients. Cardioversion was performed in 922 patients and was successful in 849 (including 22 patients with severe SEC and four with sludge) with one minor embolic event. CONCLUSION: SEC and sludge are frequently observed in patients with atrial fibrillation undergoing cardioversion. A TEE approach may prevent the risk of embolic events. In the presence of severe SEC and sludge, treating physicians frequently postpone cardioversion, even though in the patients submitted to cardioversion, no events were observed.
Authors:
Anna Maltagliati; Claudia A Galli; Gloria Tamborini; Fabrizio Celeste; Manuela Muratori; Mauro Pepi
Related Documents :
12441914 - Plasminogen activator inhibitor-1 in patients with atrial arrhythmias during acute myoc...
8646654 - Canadian atrial fibrillation anticoagulation study: were the patients subsequently trea...
8314164 - Atrial flutter followed by sick sinus syndrome as presenting symptoms of b-cell maligna...
8088024 - Left atrial thrombi despite anticoagulant and antiplatelet therapy.
21310194 - Plasma nociceptin/orphanin fq levels are lower in patients with chronic ischemic cardio...
9397304 - Cardiac involvement in behçet's disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular medicine (Hagerstown, Md.)     Volume:  10     ISSN:  1558-2027     ISO Abbreviation:  J Cardiovasc Med (Hagerstown)     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-05-28     Completed Date:  2009-07-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101259752     Medline TA:  J Cardiovasc Med (Hagerstown)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  523-8     Citation Subset:  IM    
Affiliation:
Centro Cardiologico 'I. Monzino', IRCCS, Milan, Italy. anna.maltagliati@ccfm.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Aged
Anticoagulants / administration & dosage,  therapeutic use*
Atrial Fibrillation / complications,  therapy,  ultrasonography*
Atrial Flutter / complications,  therapy,  ultrasonography*
Contrast Media / diagnostic use*
Echocardiography, Transesophageal*
Electric Countershock* / adverse effects
Embolism / etiology,  prevention & control,  ultrasonography
Female
Humans
Male
Middle Aged
Patient Selection
Thrombosis / etiology,  prevention & control,  ultrasonography*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Contrast Media

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dysphagia in patients with dementia: Alzheimer versus vascular.
Next Document:  One-stage repair of aortic coarctation and ascending aortic aneurysm by extra-anatomic graft.